2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
37
Prostatic Neoplasms
12
Triple Negative Breast Neoplasms
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Liver Neoplasms
3
Fibrosis
3
Endometrial Neoplasms
3
Carcinoma, Renal Cell
3
Carcinoma, Intraductal, Noninfiltrating
3
Uterine Cervical Neoplasms
2
Thyroid Nodule
2
Stomach Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pleural Effusion, Malignant
2
Neoplasms
2
Mouth Neoplasms
2
Lymphoma
2
Lymphedema
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Inflammatory Breast Neoplasms
2
Infertility
2
Hodgkin Disease
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Anatomic Stage III Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Wilms Tumor
1
Interventions
Doxorubicin
142
Ifosfamide
85
Radiotherapy
82
Cyclophosphamide
72
Gemcitabine
63
Filgrastim
54
pembrolizumab
43
pazopanib
40
Etoposide
39
Docetaxel
39
Vincristine
37
Trabectedin
37
Cisplatin
35
Nivolumab
32
Magnetic Resonance Spectroscopy
26
Irinotecan
26
Carboplatin
25
Temozolomide
23
Surgical Procedures, Operative
23
Radiation
22
Ipilimumab
22
Bevacizumab
20
Blood Specimen Collection
19
Granulocyte Colony-Stimulating Factor
18
Biopsy
18
eribulin
17
Sirolimus
17
Mesna
17
Melphalan
17
Dactinomycin
17
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
High-Energy Shock Waves
×
Clear all
NCT02834585
2016-07-15
MUSTT
University of Genova
Unknown
70 enrolled